Keyphrases
Radiotherapy
100%
Improved Survival
100%
Combined Modality Therapy
100%
Decitabine
100%
High-risk Medulloblastoma
100%
Abacavir
100%
Tumor Protein p53 (TP53)
62%
Ki-67
37%
CD31
37%
Group 3 Medulloblastoma
37%
Tumor Growth
25%
Quantitative PCR
25%
Therapy Approaches
25%
Adverse Effects
25%
Mouse Survival
25%
Innovative Therapies
12%
High Risk
12%
Gene Expression
12%
Tumor Histology
12%
Immune Cells
12%
Patient-derived
12%
Mouse Model
12%
Stem Cells
12%
Medulloblastoma
12%
CD133
12%
Microarray
12%
5-year Survival
12%
Cell Cycle Genes
12%
Irradiation
12%
CD68
12%
Microarray Analysis
12%
Cell Invasion
12%
Induced Effect
12%
Nestin
12%
Cell Fraction
12%
CD15
12%
Innovative Approach
12%
Neuroscience
Radiation Therapy
100%
Medulloblastoma
100%
Decitabine
100%
Abacavir
100%
TP53
62%
Microarrays
25%
Adverse Effect
25%
Staining Technique
12%
Gene Expression
12%
Stem Cell
12%
Vascular Endothelial Growth Factor
12%
Cell Cycle
12%
CD68
12%
Cell Invasion
12%
CD133
12%
Nestin
12%
CD15
12%
Medicine and Dentistry
Radiation Therapy
100%
Medulloblastoma
100%
Decitabine
100%
Abacavir
100%
Tumor Progression
25%
Adverse Event
25%
Reverse Transcription Polymerase Chain Reaction
25%
Experimental Therapy
12%
Overall Survival
12%
Tumor Histology
12%
Immunocompetent Cell
12%
Stem Cell
12%
Gene Expression
12%
Downregulation
12%
Cell Cycle
12%
Chlordane
12%
Cell Invasion
12%
Microarray Analysis
12%
Vasculotropin
12%
Nestin
12%
Immunology and Microbiology
CD31
100%
Reverse Transcription Polymerase Chain Reaction
66%
Mouse Model
33%
Stem Cell
33%
Immunocompetent Cell
33%
Gene Expression
33%
Cell Cycle
33%
Overall Survival
33%
CD68
33%
Downregulation
33%
Cell Invasion
33%
Vasculotropin
33%
CD15
33%
Pharmacology, Toxicology and Pharmaceutical Science
Medulloblastoma
100%
Decitabine
100%
Abacavir
100%
Tumor Growth
25%
Adverse Event
25%
Neoplasm
12%
Mouse Model
12%
Overall Survival
12%
Vasculotropin
12%
Chlordane
12%
Nestin
12%